Rare diseases
Investigational molecules
Locations
Back to Germany319 clinical trials in Regensburg, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
GermanyStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
GermanyStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
GermanyA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
GermanyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
GermanyAdjuvant Datopotamab Deruxtecan with Drug Combination in Patients with High‑Risk Muscle‑Invasive Urothelial Carcinoma
GermanyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
GermanyPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
GermanyEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
GermanyStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
GermanyA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
GermanyCevostamab plus pomalidomide and dexamethasone in patients with multiple myeloma previously treated with BCMA‑targeted CAR T‑cell therapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on breast cancer treatments, including studies of targeted therapies for HR-positive and HER2-negative variants. Research extends to lymphoma and leukemia treatments, with particular emphasis on combination therapies.
Multiple studies are evaluating novel drug combinations and their impact on patient survival rates.
Research focusing on preventive treatments for atopic dermatitis in high-risk pediatric populations, evaluating the effectiveness of early intervention strategies.
Studies aim to establish new preventive protocols for childhood dermatological conditions.
Investigations into treatments for pulmonary arterial hypertension and lung fibrosis, with emphasis on novel therapeutic approaches and drug safety profiles.
Current trials are exploring innovative treatments for various respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
